Clover Health Investments Corp [CLOV] stock prices are down -6.76% to $2.62 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.
From an analyst’s perspective:
Clover Health Investments Corp [NASDAQ: CLOV] stock has seen the most recent analyst activity on December 17, 2024, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $6. Previously, UBS started tracking the stock with Neutral rating on October 07, 2024, and set its price target to $4. On February 02, 2022, upgrade upgraded it’s rating to Market Perform and revised its price target to $3 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $6 on February 02, 2022. SVB Leerink initiated its recommendation with a Mkt Perform and recommended $3 as its price target on January 19, 2022. In a note dated January 07, 2022, Credit Suisse downgraded an Underperform rating on this stock and revised its target price from $9 to $3.50.
The stock price of Clover Health Investments Corp [CLOV] has been fluctuating between $2.12 and $4.87 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Clover Health Investments Corp [NASDAQ: CLOV] shares were valued at $2.62 at the most recent close of the market. An investor can expect a potential return of 14.5% based on the average CLOV price forecast.
Analyzing the CLOV fundamentals
The Clover Health Investments Corp [NASDAQ:CLOV] reported sales of 1.77B for trailing twelve months, representing a surge of 50.05%. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.17 and Total Capital is -0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Clover Health Investments Corp [NASDAQ:CLOV]’s Current Ratio is 1.71. Considering the valuation of this stock, the price to sales ratio is 0.76, the price to book ratio is 3.72.
Transactions by insiders
Recent insider trading involved Reynoso Jamie L., CEO, Medicare Advantage, that happened on Jan 07 ’26 when 2102.0 shares were sold. Officer, JAMIE REYNOSO completed a deal on Jan 07 ’26 to buy 2102.0 shares. Meanwhile, CEO, Medicare Advantage Reynoso Jamie L. sold 4913.0 shares on Dec 18 ’25.
